| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arch Therapeutics, Inc. | Director | Stock Option (right to buy) | 250,000 | 10 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTHQ | Arch Therapeutics, Inc. | 10 Nov 2022 | 1 | $0 | 4 | Director | 10 Nov 2022, 20:52 |
| ARTHQ | Arch Therapeutics, Inc. | 31 Dec 2021 | 1 | $0 | 4 | Director | 04 Jan 2022, 15:17 |
| ARTHQ | Arch Therapeutics, Inc. | 31 Dec 2021 | 0 | $0 | 3 | Director | 04 Jan 2022, 15:16 |